A detailed history of Creative Planning transactions in Care Dx, Inc. stock. As of the latest transaction made, Creative Planning holds 27,987 shares of CDNA stock, worth $446,112. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,987
Holding current value
$446,112
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$11.57 - $20.63 $323,809 - $577,371
27,987 New
27,987 $406,000
Q3 2024

Oct 11, 2024

BUY
$14.41 - $33.99 $94,198 - $222,192
6,537 New
6,537 $204,000
Q1 2023

May 15, 2023

BUY
$8.83 - $17.61 $467 - $933
53 New
53 $0

Others Institutions Holding CDNA

About CareDx, Inc.


  • Ticker CDNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 53,458,100
  • Market Cap $852M
  • Description
  • CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...
More about CDNA
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.